Prestige Consumer Healthcare

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBH and other ETFs, options, and stocks.

About PBH

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. 

CEO
Ronald M. Lombardi
CEORonald M. Lombardi
Employees
890
Employees890
Headquarters
Tarrytown, New York
HeadquartersTarrytown, New York
Founded
1996
Founded1996
Employees
890
Employees890

PBH Key Statistics

Market cap
2.27B
Market cap2.27B
Price-Earnings ratio
14.23
Price-Earnings ratio14.23
Dividend yield
—
Dividend yield—
Average volume
745.48K
Average volume745.48K
High today
$48.28
High today$48.28
Low today
$46.69
Low today$46.69
Open price
$46.70
Open price$46.70
Volume
215.95K
Volume215.95K
52 Week high
$71.07
52 Week high$71.07
52 Week low
$41.77
52 Week low$41.77

Stock Snapshot

As of today, Prestige Consumer Healthcare(PBH) shares are valued at $47.85. The company's market cap stands at 2.27B, with a P/E ratio of 14.23.

As of 2026-11-16, Prestige Consumer Healthcare(PBH) stock has fluctuated between $46.69 and $48.28. The current price stands at $47.85, placing the stock +2.5% above today's low and -0.9% off the high.

The Prestige Consumer Healthcare(PBH)'s current trading volume is 215.95K, compared to an average daily volume of 745.48K.

In the last year, Prestige Consumer Healthcare(PBH) shares hit a 52-week high of $71.07 and a 52-week low of $41.77.

In the last year, Prestige Consumer Healthcare(PBH) shares hit a 52-week high of $71.07 and a 52-week low of $41.77.

PBH News

Investing.com 1d
how InvestingPro spotted Prestige Healthcare’s 46% decline By Investing.com - Investing.com

...

how InvestingPro spotted Prestige Healthcare’s 46% decline By Investing.com - Investing.com
Simply Wall St 3d
Prestige Consumer Healthcare Could Be 33% Undervalued As 2027 Guidance Softens

Why Prestige Consumer Healthcare is in focus after new earnings and guidance Prestige Consumer Healthcare (PBH) drew investor attention after reporting second...

Prestige Consumer Healthcare Could Be 33% Undervalued As 2027 Guidance Softens
Simply Wall St 4d
What Prestige Consumer Healthcare's Lower Revenue Outlook Means For Shareholders

Prestige Consumer Healthcare reported second quarter 2026 results with sales of US$332.9 million and revenue of US$336.31 million, while net income and diluted...

What Prestige Consumer Healthcare's Lower Revenue Outlook Means For Shareholders

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

People also own

Based on the portfolios of people who own PBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.